Cancer drugs: Phase II clinical studies enough for registration.

Published: 2002-11-12 06:57:00

Updated: 2002-11-12 06:57:00

The KFDA may approve the product registration for anti-cancer drugs only with the phase II clinical study data to speed up the drug development and help cancer patients to get an appropriate treatment utmost timely, admitting the clinical phase II studies enough to identify its efficacy and safet...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK